4//SEC Filing
Hamm John M. 4
Accession 0001209191-22-026140
CIK 0001087294other
Filed
Apr 28, 8:00 PM ET
Accepted
Apr 29, 1:02 PM ET
Size
6.9 KB
Accession
0001209191-22-026140
Insider Transaction Report
Form 4
Hamm John M.
Chief Financial Officer
Transactions
- Award
Options (right to buy)
2022-03-16+2,000→ 2,000 totalExercise: $2.59From: 2026-03-16Exp: 2032-03-16→ Common Stock (2,000 underlying) - Award
Common Stock
2022-03-16$2.59/sh+20,000$51,800→ 26,800 total
Footnotes (2)
- [F1]100% vesting on March 16, 2025.
- [F2]100% vesting on March 16, 2026.
Documents
Issuer
CUMBERLAND PHARMACEUTICALS INC
CIK 0001087294
Entity typeother
Related Parties
1- filerCIK 0001870439
Filing Metadata
- Form type
- 4
- Filed
- Apr 28, 8:00 PM ET
- Accepted
- Apr 29, 1:02 PM ET
- Size
- 6.9 KB